Jpmorgan Chase & CO Icu Medical Inc Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Icu Medical Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 702,487 shares of ICUI stock, worth $81.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

702,487

Previous 708,382 0.83%

Holding current value

$81.7 Million

Previous $110 Million 11.26%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$130.05 - $172.3 $766,644 - $1.02 Million	-5,895 Reduced 0.83%	702,487 $97.5 Million
Q4 2024 Feb 12, 2025	BUY	$153.2 - $183.79 $7.52 Million - $9.03 Million	49,108 Added 7.45%	708,382 $110 Million
Q3 2024 Dec 26, 2024	SELL	$114.88 - $182.17 $13.8 Million - $21.8 Million	-119,903 Reduced 15.39%	659,274 $120 Million
Q3 2024 Nov 08, 2024	SELL	$114.88 - $182.17 $13.8 Million - $21.8 Million	-119,903 Reduced 15.39%	659,274 $120 Million
Q2 2024 Dec 26, 2024	BUY	$94.53 - $120.55 $11.3 Million - $14.5 Million	119,903 Added 18.19%	779,177 $92.5 Million
Q2 2024 Aug 12, 2024	SELL	$94.53 - $120.55 $3.66 Million - $4.67 Million	-38,740 Reduced 4.74%	779,177 $92.5 Million
Q1 2024 Dec 26, 2024	BUY	$86.88 - $112.48 $13.8 Million - $17.8 Million	158,643 Added 24.06%	817,917 $87.8 Million
Q1 2024 May 10, 2024	BUY	$86.88 - $112.48 $6.87 Million - $8.89 Million	79,025 Added 10.7%	817,917 $87.8 Million
Q4 2023 Dec 26, 2024	BUY	$81.08 - $119.29 $6.46 Million - $9.5 Million	79,618 Added 12.08%	738,892 $73.7 Million
Q4 2023 Feb 12, 2024	BUY	$81.08 - $119.29 $913,609 - $1.34 Million	11,268 Added 1.55%	738,892 $73.7 Million
Q3 2023 Nov 14, 2023	BUY	$115.27 - $182.23 $416,239 - $658,032	3,611 Added 0.5%	727,624 $86.6 Million
Q2 2023 Aug 11, 2023	SELL	$161.03 - $209.15 $8.97 Million - $11.6 Million	-55,692 Reduced 7.14%	724,013 $129 Million
Q1 2023 May 18, 2023	BUY	$153.15 - $198.21 $5.3 Million - $6.86 Million	34,615 Added 4.65%	779,705 $129 Million
Q1 2023 May 11, 2023	SELL	$153.15 - $198.21 $1.43 Million - $1.85 Million	-9,331 Reduced 1.24%	745,090 $123 Million
Q4 2022 Feb 13, 2023	BUY	$136.25 - $165.56 $1.12 Million - $1.37 Million	8,256 Added 1.11%	754,421 $119 Million
Q3 2022 Nov 14, 2022	SELL	$149.44 - $188.1 $1.87 Million - $2.36 Million	-12,537 Reduced 1.65%	746,165 $112 Million
Q2 2022 Aug 11, 2022	SELL	$161.4 - $229.7 $6.95 Million - $9.89 Million	-43,057 Reduced 5.37%	758,702 $125 Million
Q1 2022 May 11, 2022	SELL	$203.51 - $247.46 $14.4 Million - $17.5 Million	-70,572 Reduced 8.09%	801,759 $179 Million
Q4 2021 Feb 10, 2022	BUY	$220.96 - $247.44 $1.24 Million - $1.39 Million	5,630 Added 0.65%	872,331 $207 Million
Q3 2021 Nov 12, 2021	BUY	$186.8 - $260.0 $162 Million - $225 Million	866,701 New	866,701 $202 Million

Others Institutions Holding ICUI

# of Institutions

304

Shares Held

25M

Call Options Held

32.5K

Put Options Held

2.1K

View Full List

About ICU MEDICAL INC

Ticker ICUI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 23,899,400
Market Cap $2.78B
Description
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and Swa...

More about ICUI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Icu Medical Inc Transaction History